EICHOR

Recruiting studies: Hypertension Pulmonary Arterial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814 Exercise-based Rehabilitation in Patients With Pulmonary Arterial Hypertension
NA · 1 location(s) · Tampere Heart Hospital · NCT06804122 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NA · 68 location(s) · Abbott Medical Devices · NCT06526195 Rutgers University Study of the Genetics of Pulmonary Hypertension
Phase N/A · 1 location(s) · Rutgers, The State University of New Jersey · NCT07217522 A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Phase 2 · 6 location(s) · Apollo Therapeutics Ltd · NCT06846554 Development of Novel Physiological CMR Methods in Health and Disease
NA · 1 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT03854071 A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants
Phase 3 · 2 location(s) · Insmed Incorporated · NCT07481981 A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
Phase 1 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06554301 Efficacy and Safety of Qishen Yiqi Dropping Pills in Patients With Severe Pulmonary Hypertension
NA · 1 location(s) · Guangdong Provincial People's Hospital · NCT07604805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Phase 4 · 19 location(s) · AOP Orphan Pharmaceuticals AG · NCT06317805 Pulmonary Hypertension SOLAR
Phase 2 · 1 location(s) · Bastiaan Driehuys · NCT04778046 Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Phase N/A · 1 location(s) · ChromX Health · NCT06528418 DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
Phase N/A · 1 location(s) · Polish Cardiology Association · NCT03959748 Real-World Study of PADN for the Treatment of PAH
Phase N/A · 1 location(s) · Pulnovo Medical (Wuxi) Co., Ltd. · NCT07039604 Study of Intravenous ZMA001 in Healthy Subjects
Phase 1 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05967299 REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)
Phase N/A · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT05665556 Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT05584722 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · 48 location(s) · Pfizer · NCT07073820 Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
Phase 1 · 1 location(s) · Pharmosa Biopharm Inc. · NCT06429930 AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07457762 A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Phase 3 · 129 location(s) · Merck Sharp & Dohme LLC · NCT07218029 PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT06998329 A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
Phase 1 · 1 location(s) · Joseph C. Wu · NCT06872112 National Registry and Cohort Study of Pulmonary Vascular Disease
Phase N/A · 13 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT05368467 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Phase 3 · 5 location(s) · AOP Orphan Pharmaceuticals AG · NCT06350032 Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT07120789 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
Phase 2 · 1 location(s) · Bastiaan Driehuys · NCT06104228 DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
Phase 1/Phase 2 · 5 location(s) · Diagonal Therapeutics, Inc. · NCT07623525 Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced
Phase 2 · 1 location(s) · West China Hospital · NCT06859684 PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND PO
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06917196

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →